FISHAWACK MEDICAL COMMUNICATIONS LIMITED

08279590
Active London

Activities of head offices

3 employees website.com
Activities of head offices
F

FISHAWACK MEDICAL COMMUNICATIONS LIMITED

08279590

Activities of head offices

Founded 2 Nov 2012 Active London, United Kingdom 3 employees website.com
Activities of head offices

Previous Company Names

FISHAWACK GROUP LIMITED 11 Jun 2013 — 7 Aug 2018
FISHAWACK HOLDCO LIMITED 12 Feb 2013 — 11 Jun 2013
SANDCO 1249 LIMITED 2 Nov 2012 — 12 Feb 2013
Accounts Submitted 27 Nov 2025 Next due 31 Dec 2026 5 months remaining
Confirmation Submitted 14 Oct 2025 Next due 14 Oct 2026 3 months remaining
Net assets £19M £3M 2024 year on year
Total assets £103M £5M 2024 year on year
Total Liabilities £84M £8M 2024 year on year
Charges 13
2 outstanding 11 satisfied

Contact & Details

Contact

Registered Address

The Featherstone Building 66 City Road London EC1Y 2AL United Kingdom

Full company profile for FISHAWACK MEDICAL COMMUNICATIONS LIMITED (08279590), an active company based in London, United Kingdom. Incorporated 2 Nov 2012. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type audit-exemption-subsidiary
Next accounts 31 Mar 2026
Due by 31 Dec 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

N/A

Net Assets

£18.54M

Decreased by £2.89M (-14%)

Total Liabilities

£84.50M

Increased by £8.02M (+10%)

Turnover

N/A

Employees

3

Debt Ratio

82%

Increased by 4 (+5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (3)

Avalere Health Group Limited
48.4%
208,340
Avalere Health Group Limited
45.1%
194,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 29 Jan 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Dominic Thomas Miller

Ceased 6 Apr 2016

Ceased

Growth Capital Partners Llp

Ceased 29 Jan 2017

Ceased

Group Structure

Group Structure

FISHAWACK MEDICAL COMMUNICATIONS LIMITED Current Company

Charges

Charges

2 outstanding 11 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Mar 2026OfficersAppointment of Mr Toby Matthew Skelton as director on 23 Feb 2026
9 Mar 2026OfficersTermination of John Richard Gransee as director on 23 Feb 2026
3 Dec 2025OfficersTermination of Amanda Vernon as director on 26 Nov 2025
27 Nov 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
27 Nov 2025AccountsAnnual accounts made up to 31 Mar 2025
9 Mar 2026 Officers

Appointment of Mr Toby Matthew Skelton as director on 23 Feb 2026

9 Mar 2026 Officers

Termination of John Richard Gransee as director on 23 Feb 2026

3 Dec 2025 Officers

Termination of Amanda Vernon as director on 26 Nov 2025

27 Nov 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

27 Nov 2025 Accounts

Annual accounts made up to 31 Mar 2025

Recent Activity

Latest Activity

Appointment of Mr Toby Matthew Skelton as director on 23 Feb 2026

3 months ago on 9 Mar 2026

Termination of John Richard Gransee as director on 23 Feb 2026

3 months ago on 9 Mar 2026

Termination of Amanda Vernon as director on 26 Nov 2025

7 months ago on 3 Dec 2025

Audit exemption statement of guarantee by parent company for period ending 31/03/25

7 months ago on 27 Nov 2025

Annual accounts made up to 31 Mar 2025

7 months ago on 27 Nov 2025